510(k) K200279
K200279 is an FDA 510(k) premarket notification submitted by Phadia AB for the device "ImmunoCAP Allergen o215, Component nGal-alpha-1,3-Gal(alpha-Gal) Thyroglobulin, bovine". The FDA issued a decision of Substantially Equivalent on May 1, 2020. The device falls under product code DHB (System, Test, Radioallergosorbent (Rast) Immunological), a Class II device regulated under 21 CFR 866.5750. Phadia AB has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 1, 2020
- Date Received
- February 4, 2020
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Radioallergosorbent (Rast) Immunological
- Device Class
- Class II
- Regulation Number
- 866.5750
- Review Panel
- IM
- Submission Type